- Home
- RMCF vs CVKD Comparison
RMCF vs CVKD Comparison
Compare RMCF & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMCF | CVKD |
|---|---|---|
| Founded | 1981 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3M | 17.0M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | RMCF | CVKD |
|---|---|---|
| Price | $2.40 | $6.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | ★ 77.9K | 54.0K |
| Earning Date | 01-13-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $29,638,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.08 | N/A |
| 52 Week Low | $1.12 | $6.42 |
| 52 Week High | $2.60 | $22.90 |
Technical Indicators
Market Signals| Indicator | RMCF | CVKD |
|---|---|---|
| Relative Strength Index (RSI) | 68.70 | 33.95 |
| Support Level | $2.21 | $7.07 |
| Resistance Level | $2.60 | $8.21 |
| Average True Range (ATR) | 0.19 | 0.57 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 81.91 | 7.89 |
Price Performance
Historical ComparisonAbout RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.